US expands lawsuit against Huawei with charges of theft & racketeering
By Akshay Kedari  Date: 2020-02-15

US expands lawsuit against Huawei with charges of theft & racketeering

The United States Department of Justice has recently expanded its lawsuit against Huawei, a Chinese multinational tech company. The new charges against the company alleged activities carried out by Huawei such as violating partnership terms with U.S. companies and stealing trade secrets such as source code and robot technology from half a dozen of rival competitors in America.

The Justice Department also alleged that the company helped Iran track protesters during anti-government demonstrations in Tehran, by providing surveillance equipment in 2009. The lawsuit also claims that the company sought to hide its business practices in North Korea despite economic sanctions in the region.

According to the latest indictment, the company was charged for plotting to steal intellectual property by hiring employees from rival companies, along with incentives provided to employees who brought in stolen business information, which include user manuals as well as robot testing technology and antenna, with an aim to save R&D costs.

For instance, the company’s engineer reportedly removed a robot arm from a rival company’s laboratory, clicked pictures and sent the measurement records to Huawei before the arm had been returned. Apart from these, the company is already facing a criminal case in New York, based on the   company alleged attempts to conceal all business dealings with North Korea and Iran by referring to the countries by code names in their internal documents.

Additionally, Meng Wanzhou, CFO and the daughter of Huawei’s founder, is being held in Vancouver, British Columbia, charged with supplying false information to banks regarding the company’s affiliations in Iran.

The Chinese tech giant has said that the allegations were made without merits accusing the US administration of economic e-bullying, for irrevocably hurting the company’s reputation. The Trump administration is working to isolate the company from expanding its foothold in the U.S. as well as globally. Citing national security concerns, the U.S. has been forming Western allies to bar the company from utilizing high-speed Internet networks across various locations worldwide.

Source credit:

https://apnews.com/afef0950754963939cb617cc4436ea1c

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...